Medicine Information

The P Value And Its Significance

When diversifying an investment portfolio, one needs to consider investing in the healthcare industries. Pharmaceutical companies that have strong pipelines of investigation drugs have strong growth speculations. In addition to examining its pipelines, one also needs to be able to evaluate the results of its clinical trials. When a news program reports the results of a clinical trial for a new drug to be "statistically significant," what does it mean? And how did they come up with that conclusion? One of the most important values to look for when interpreting the results of a study is the P value.

Elenbaas et al defines P value as "the probability that a type I error has been committed, and that the null hypothesis has been falsely rejected." Let's briefly talk about the null hypothesis, type I error, and type II error. Lets say a new drug A is being compared to a currently available drug B. The first assumption that investigators will make is that the new drug A is equivalent or is equal in efficacy to the currently available drug B. This assumption is called the null hypothesis (H0). A contradicting assumption to the null hypothesis is the alternative hypothesis (H1). H1 says that the new drug A is more effective than the currently available drug B. In fact, the alternative hypothesis (H1) is what the investigators want to prove because the pharmaceutical companies developing the new drugs fund most of its clinical trials. Type I error occurs when H0 is rejected when it is really true. In other words, investigators believe that the new drug A is more effective than the currently available drug B (rejecting H0), when drug A is equal in efficacy to drug B, or worst, not as effective as drug B. Type II error occurs when H1 is actually true (drug A is more effective than drug B), but the investigators failed to reject H0 (did not reject the hypothesis that drug A is equal in efficacy as drug B).

With the technical terminologies defined, lets go back to the P value. To reiterate, P value is "the probability that a type I error has been committed, and that the null hypothesis has been falsely rejected." (Elenbass et al). The P value is said to be "statistically significant" when it is < 0.05. For example, a clinical trial comparing the effectiveness between drug A and drug B, found that drug A worked better at lowering the blood pressure than drug B, and the P value was calculated to be 0.04. This means that there is a 4% chance that a type I error is being committed (investigators falsely believe that drug A is more effective than drug B, when they are equal in efficacy). 0.05 is the largest acceptable P value in clinical literature. When investigators claim that drug A is more effective than drug B, they were correct 95% of the time, with only less than 5% chance error.

There are many other important statistical values, but they are beyond the scope of this article. Now, whenever a reporter on television reports the results of a clinical trial for a new drug to be "statistically significant," one can perform their own verification by obtaining a copy of that study and look for the P value.


1. Elenbaas RM, Elenbass JK, and Cuddy PG, et al. Evaluating the medical literature part II: statistical analysis. Annals of Emergency Medicine. October 1983;12(10):35-45.

2. Anderson HG, Kendrach MG, and Trice S, et al. Understanding statistical and clinical significance: hypothesis testing. Journal of pharmacy practice. June 1998;11(3):181-195.

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

New York Post

Venezuelans with transplants live in fear as medicine runs out
New York Post
After years leading normal lives, they now live in fear as Venezuela's economic collapse under President Nicolas Maduro has left the once-prosperous OPEC nation unable to purchase sufficient foreign medicine or produce enough of its own. Some 31 ...
PETRO's backing (from Whitepaper) - El PetroEl Petro
Venezuela: 82.4M Units of Petro Cryptocurrency AvailableteleSUR English

all 177 news articles »

#MeToo in medicine: Women, harassed in hospitals and operating ...
In a months-long investigation, NBC News spoke with nearly a dozen women and experts who described widespread misconduct in hospitals and health care.

and more »


Gastrointestinal Cancers Entering Age of Precision Medicine
He: We had 4 excellent faculty who talked about the updates to pancreatic and hepatobiliary cancer treatment, treatment of neuroendocrine tumors (NETs) of the GI tract, and precision medicine. Molecular profiling has been identified as a very important ...

The Courier-Journal

University of Louisville takes its medicine and starts healing process | Tim Sullivan
The Courier-Journal
There's never a wrong time to do the right thing. There's rarely a point where a public institution is better served by technicalities than truth. The University of Louisville has paid a high price for coming clean with its dirty laundry, with self ...

and more »

Ayurveda: a 5000 year old tradition of eating where food is medicine
Singer songwriter Nicki Bluhm is the latest guest on my podcast, Your Last Meal. For her last meal she wants a classic steakhouse dinner, complete with scalloped potatoes and creamed spinach. But in her daily life, she follows an Ayurvedic diet; a 5 ...


4 ways AI could help shape the future of medicine
At times, progress occurs so quickly that it's difficult to separate science fiction from real life. Just five decades ago, computers were massive, unwieldy machines running on punch cards and primitive circuits. Today, a single smartphone has more ...

PR Newswire (press release)

Personalized Lifestyle Medicine Institute to Host 2018 Thought Leaders Consortium in Tucson
PR Newswire (press release)
SEATTLE, Feb. 20, 2018 /PRNewswire/ -- The Personalized Lifestyle Medicine Institute (PLMI) will host the Sixth Annual Thought Leaders Consortium Oct. 12-13, 2018 at the Westin La Paloma Resort and Spa in Tucson, Arizona. The title of the 2018 ...

and more »

Equities Focus

Loxo Oncology Will Fulfill The Promise Of Precision Medicine
Seeking Alpha
Based in Stamford, Connecticut, Loxo Oncology is dedicated to developing precision medicines against genetically defined cancers. Its highly selective drugs in the pipeline will shift the paradigm of cancer treatment from the traditional "one-size-fits ...
Financial Newsletter - ZacksZacks
Loxo Oncology, Inc. - LOXO - Stock Price Today - ZacksZacks

all 39 news articles »

Huntington Herald Dispatch

UCD School of Medicine scores high in NIH research funding
Davis Enterprise
For the first time, UC Davis School of Medicine has ranked in the top 20 percent of institutions in the country for research funding from the National Institutes of Health. “The proportion of NIH funding is an important measure of research excellence ...
National Institutes of Health guests visit School of MedicineHNN

all 3 news articles »

Centralia Chronicle

Chehalis Family Medicine Residency Program Aims to Improve Quality of Care in Rural Areas
Centralia Chronicle
For the past three years, the Chehalis Family Medicine clinic has been operating a rural residency program in an effort to improve the standards of care received by its patients. In rural areas, which includes the vast majority of Southwest Washington ...

Google News

home | site map | Dr. Thad Thomas
© 2006